Tao Wen

8PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social determinants of healthMolecular targetsHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 22, 2026
A Dual-Action CXCR4-Targeted Peptide-Drug Conjugate Engineered to Enhance Antitumor Efficacy and Mitigate Myelosuppression in Pancreatic Cancer.

|Apr 13, 2026
Magnetically Actuated Iron Oxide Nanoparticles Sensitize Acute T-Lymphocyte Leukemia Cells to Vincristine via Reprogramming Cellular Homeostasis.

Hang Wu, Tao Wang, Chuanmei Jiang

|Aug 06, 2025
Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabine.

Xin Huang, Hang Wu, Ke Zhu

|Sep 02, 2024
Antioxidant Carbon Dots Nanozymes Alleviate Stress-induced Depression by Modulating Gut Microbiota.

Huimin Jia, Jiawen Gong, Zheyuan Hu

|Apr 05, 2023
CXC Chemokine Receptor Type 4 Antagonistic Gold Nanorods Induce Specific Immune Responses and Long-Term Immune Memory to Combat Triple-Negative Breast Cancer.

Yiling Meng, Jiawei Zhou, Xuanxin Liu

|Aug 17, 2022
CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid Leukemia.

Shilin Xu, Meichen Zhang, Xiaocui Fang

Pageof 2

Frequent Collaborators

7 joint publications

Haiyan Xu

2 joint publications

Weiwei He

2 joint publications

Yanlian Yang

2 joint publications

Xiaocui Fang